Royalty Pharma Sub-Manager

Asset Manager SEC-registered adviser

Legal name: Royalty Pharma Sub-Manager, LLC

New York, NY Website LinkedIn

AUM

$19.6B
Regulatory AUM

Private funds

2
Private Equity 2

Private fund assets

$1.4B
Gross asset value

Employees

91

Last Form D raise

Feb 2020
Most recent fund filing

From SEC Form ADV filing (filed May 4, 2026). View on SEC

People(3)

Owners and executive officers named on the firm's SEC Form ADV.

A
Arthur McGivern
Executive Vice President and General Counsel
Source: SEC Form ADV
P
Pablo Legorreta
Chief Executive Officer
Source: SEC Form ADV
T
Terrance Coyne
Executive Vice President and Chief Financial Officer
Source: SEC Form ADV

Funds(2)

Private funds reported on Form ADV, with amounts raised from the funds' SEC Form D filings.

FundTypeGross assetsRaised (Form D)InvestorsLast Form DRecency
Rpi US Partners 2019, LPPrivate Equity$1.4B——Feb 2020Cold
Rpi International Partners 2019, LPPrivate Equity$6.8M——Feb 2020Cold

Board seats

Companies whose SEC Form D filings name one of this firm's people as a director, matched by name and office ZIP code.

No board seats matched from SEC filings yet.

Regulatory identifiers

CRD number
335070
SEC file number
801-132133

Sources